Cargando…
Advances in CRISPR therapeutics
The clustered regularly interspaced short palindromic repeats (CRISPR) renaissance was catalysed by the discovery that RNA-guided prokaryotic CRISPR-associated (Cas) proteins can create targeted double-strand breaks in mammalian genomes. This finding led to the development of CRISPR systems that har...
Autores principales: | Chavez, Michael, Chen, Xinyi, Finn, Paul B., Qi, Lei S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589773/ https://www.ncbi.nlm.nih.gov/pubmed/36280707 http://dx.doi.org/10.1038/s41581-022-00636-2 |
Ejemplares similares
-
CRISPR-Based Therapeutic Gene Editing for Duchenne Muscular Dystrophy: Advances, Challenges and Perspectives
por: Chen, Guofang, et al.
Publicado: (2022) -
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
por: Zhou, Lifang, et al.
Publicado: (2023) -
CRISPR/Cas9 therapeutics: progress and prospects
por: Li, Tianxiang, et al.
Publicado: (2023) -
Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022) -
CRISPR Therapeutics for Duchenne Muscular Dystrophy
por: Erkut, Esra, et al.
Publicado: (2022)